Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Man Lin

Showing results (221-230 of 223) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 223 results.
Cellular and Molecular Life Sciences : CMLS|February 10, 2024
BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinomaZongdong Yu, Xiang Wu, Jie Zhu, et al.
Transplantation|April 6, 2018
Prediction of the Development of Persistent Massive Ascites After Living Donor Liver Transplantation Using a Perioperative Risk ScoreYi-Ju Wu, Shih-Ho Wang, Ahmed M Elsarawy, et al.
Frontiers in Oncology|August 15, 2022
Baseline serum uric acid level is associated with progression-free survival, disease control rate, and safety in postoperative patients with colorectal cancer treated by FOLFOX, FOLFIRI, or XELOXXi Zhang, Qing-Hong Chen, Ying Yang, et al.
Pageof 23

Showing results (221-230 of 223) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 223 results.
Cellular and Molecular Life Sciences : CMLS|February 10, 2024
BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinomaZongdong Yu, Xiang Wu, Jie Zhu, et al.
Transplantation|April 6, 2018
Prediction of the Development of Persistent Massive Ascites After Living Donor Liver Transplantation Using a Perioperative Risk ScoreYi-Ju Wu, Shih-Ho Wang, Ahmed M Elsarawy, et al.
Frontiers in Oncology|August 15, 2022
Baseline serum uric acid level is associated with progression-free survival, disease control rate, and safety in postoperative patients with colorectal cancer treated by FOLFOX, FOLFIRI, or XELOXXi Zhang, Qing-Hong Chen, Ying Yang, et al.
Pageof 23